MORE ON: PhRMA

The California State Auditor is urging Medi-Cal to take a more aggressive stance in resolving disputes over hundreds of millions in drug rebates that pharmaceutical firms may owe the state. The matter has been raised in numerous audits throughout the last 10 years, but takes on additional... + read more